Ghost Tree Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.05M Buy
+325,000
New +$1.05M 0.32% 50
2024
Q1
Hold
0
66
2023
Q4
Sell
-215,000
Closed -$3.94M 47
2023
Q3
$3.94M Sell
215,000
-335,000
-61% -$6.13M 1.29% 22
2023
Q2
$11.9M Buy
550,000
+75,000
+16% +$1.62M 3.92% 8
2023
Q1
$13.9M Buy
475,000
+125,000
+36% +$3.67M 4.12% 2
2022
Q4
$12.9M Sell
350,000
-200,000
-36% -$7.39M 5.52% 6
2022
Q3
$15.5M Buy
+550,000
New +$15.5M 4.35% 4